- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Novanta Inc(NOVT)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NOVT
11/13/2026: NOVT (1-star) is currently NOT-A-BUY. Pass it for now.
Novanta Inc is a specialized industrial technology firm supplying critical precision components to medical and advanced industrial OEMs. The stock is a growth-oriented play, known for its deep integration into high-specification equipment, which creates significant switching costs. Its primary investment story revolves around structural growth in surgical robotics and automated medical diagnostic tools. Key risks include a high valuation that requires flawless growth, reliance on M&A integration, and cyclical exposure to industrial spending. Novanta is well-suited for long-term growth investors who monitor its success in expanding medical recurring revenue and maintaining competitive design-win advantages in its core technological niches.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company targets high-growth end markets like surgical robotics and precision medicine. |
| Momentum investor | Strong fit while signal remains positive | The stock has historically attracted interest during phases of significant organic revenue acceleration. |
| Value investor | Mixed fit | Valuation often trades at a premium multiple, which may deter traditional value-oriented investors. |
| Dividend investor | Weak fit | Novanta does not currently pay a dividend, prioritizing capital for M&A and R&D. |
| Low-risk investor | Mixed fit | While the business has high-quality, recurring revenues, the stock's beta and valuation-driven volatility can present risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock's valuation premium and cyclical end-market exposure can lead to significant short-term price swings. |
| Valuation risk | Medium / high | The stock is often priced for perfection, leaving little room for error if growth forecasts are missed. |
| Competition risk (Specialized industrial peers) | Medium | While the company has a moat, it faces continuous pressure from specialized competitors in specific technology niches. |
| Business quality | Strong | The company's deep OEM design-in positions provide long-term, structurally stable revenue foundations. |
| Dividend income | Low / none | Investors should not look to this stock for regular income payouts. |
| Execution risk | Medium / high | The company relies heavily on successfully integrating large acquisitions to meet growth targets. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.50B USD | Price to earnings Ratio 90.06 | 1Y Target Price 185 |
Price to earnings Ratio 90.06 | 1Y Target Price 185 | ||
Volume (30-day avg) 517.6K shares | Beta 1.7 | 52 Weeks Range 98.27 - 176.38 | Updated Date 11/14/2026 |
52 Weeks Range 98.27 - 176.38 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.32 |
Sector & Industry Intelligence
Sector
Technology
Caution- Sentiment
- Near Bearish
- Momentum
- Rapid Breadth Deterioration
- BUY participation
- 30.1%
- Active BUY / eligible
- 37 / 123
- 30-Day BUY Count Change
- -42
- Market state
- Weak Bullish / Near Bearish
BUY participation is falling rapidly, suggesting elevated market vulnerability.
Industry
Scientific & Technical Instruments
- BUY participation
- 0.0%
- Active BUY / eligible
- 0 / 4
- 30-Day BUY Count Change
- -2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -40.82% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Medical Solutions | Subsystems for surgery, diagnostics, and patient care; includes consumables. | This is the company's most stable, recurring revenue engine, driven by the growth of medical procedures. |
| Automation Enabling Technologies | Precision motion, robotics components, and laser technology. | This area provides cyclical upside as manufacturing and robotics industries invest in precision. |
| Geography (International) | Operations and sales across Europe, Asia, and the Americas. | Significant non-US exposure means the company is sensitive to global trade costs and currency fluctuations. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-09 | When After Market | Estimate 0.97 | Actual 1.05 |
Profitability
Profit Margin 4.89% | Operating Margin (TTM) 11.76% |
Management Effectiveness
Return on Assets (TTM) 3.42% | Return on Equity (TTM) 4.38% |
Valuation
Trailing PE 90.06 | Forward PE 8.39 | Enterprise Value 5.18B | Price to Sales(TTM) 4.14 |
Enterprise Value 5.18B | Price to Sales(TTM) 4.14 | ||
Enterprise Value to Revenue 4.77 | Enterprise Value to EBITDA 25.68 | Shares Outstanding 37.82M | Shares Floating 37.54M |
Shares Outstanding 37.82M | Shares Floating 37.54M | ||
Percent Insiders 0.87 | Percent Institutions 122.51 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

